Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
GLYC's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: No Debt )
GLYC' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.95
GLYC's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 0.95 )
GLYC' s 10-Year Equity to Asset Range
Min: 0.55   Max: 0.95
Current: 0.95

0.55
0.95
Interest Coverage No Debt
GLYC's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: No Debt )
GLYC' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

Z-Score: 25.29
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -265.19
GLYC's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: -265.19 )
GLYC' s 10-Year Operating margin (%) Range
Min: -265.19   Max: 24
Current: -265.19

-265.19
24
Net-margin (%) -265.61
GLYC's Net-margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: -265.61 )
GLYC' s 10-Year Net-margin (%) Range
Min: -265.61   Max: 23.96
Current: -265.61

-265.61
23.96
ROE (%) -364.84
GLYC's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: -364.84 )
GLYC' s 10-Year ROE (%) Range
Min: -364.84   Max: 29.18
Current: -364.84

-364.84
29.18
ROA (%) -200.76
GLYC's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: -200.76 )
GLYC' s 10-Year ROA (%) Range
Min: -200.76   Max: 19.85
Current: -200.76

-200.76
19.85
ROC (Joel Greenblatt) (%) -1525.79
GLYC's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: -1525.79 )
GLYC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2589.36   Max: 811.97
Current: -1525.79

-2589.36
811.97
» GLYC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

GLYC Guru Trades in

GLYC Guru Trades in

Q1 2014

GLYC Guru Trades in Q1 2014

Steven Cohen 28,648 sh (New)
» More
Q2 2014

GLYC Guru Trades in Q2 2014

George Soros 10,300 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with GLYC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2014-06-30 New Buy$6.12 - $16.76 $ 8.15-18%10300
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.41
GLYC's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 2.41 )
GLYC' s 10-Year P/B Range
Min: 1.81   Max: 2.72
Current: 2.41

1.81
2.72
P/S 10.19
GLYC's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 10.19 )
GLYC' s 10-Year P/S Range
Min: 7.65   Max: 11.51
Current: 10.19

7.65
11.51
EV-to-EBIT -19.01
GLYC's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: -19.01 )
GLYC' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -19.01

Current Ratio 18.65
GLYC's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 18.65 )
GLYC' s 10-Year Current Ratio Range
Min: 2.14   Max: 21.83
Current: 18.65

2.14
21.83
Quick Ratio 18.65
GLYC's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 18.65 )
GLYC' s 10-Year Quick Ratio Range
Min: 2.14   Max: 21.83
Current: 18.65

2.14
21.83

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.46
GLYC's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 2.46 )
GLYC' s 10-Year Price/Net Cash Range
Min: 2.32   Max: 5.65
Current: 2.46

2.32
5.65
Price/Net Current Asset Value 2.46
GLYC's Price/Net Current Asset Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 2.46 )
GLYC' s 10-Year Price/Net Current Asset Value Range
Min: 2.32   Max: 5.65
Current: 2.46

2.32
5.65
Price/Tangible Book 2.42
GLYC's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 2.42 )
GLYC' s 10-Year Price/Tangible Book Range
Min: 2.28   Max: 5.54
Current: 2.42

2.28
5.54
Price/Median PS Value 1.03
GLYC's Price/Median PS Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. GLYC: 1.03 )
GLYC' s 10-Year Price/Median PS Value Range
Min: 0.97   Max: 0.97
Current: 1.03

Business Description

Industry: »
Compare: » details
Traded in other countries:GKO.Germany
» More Articles for GLYC

Headlines

Articles On GuruFocus.com
No related article found.


More From Other Websites
BioMed Realty Inks Lease Agreement with GlycoMimetics in MD Aug 29 2014
Nasdaq stocks posting largest percentage increases Aug 28 2014
BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science |... Aug 26 2014
GLYCOMIMETICS INC Financials Aug 08 2014
GlycoMimetics to Present at 34th Annual Canaccord Genuity Global Growth Conference Aug 08 2014
GLYCOMIMETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
GLYCOMIMETICS INC Files SEC form 10-Q, Quarterly Report Jul 31 2014
GlycoMimetics Reports Second Quarter 2014 Results Jul 31 2014
GLYCOMIMETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 28 2014
GLYCOMIMETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jul 10 2014
GlycoMimetics Appoints Mark A. Goldberg, M.D. to Board of Directors Jul 10 2014
GlycoMimetics Up on FDA Agreement on Rivipansel Study Jul 02 2014
GlycoMimetics to Present at Jefferies Healthcare Conference May 28 2014
Options For Pfizer Investors May 22 2014
GlycoMimetics receives $15M payment from Pfizer related to rivipansel May 20 2014
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of... May 20 2014
GlycoMimetics announces presentation of GMI-1070 data May 15 2014
GlycoMimetics Announces Presentation of Rivipansel Data in Pediatric Patients at American Society of... May 15 2014
GLYCOMIMETICS INC Files SEC form 10-Q, Quarterly Report May 09 2014
GLYCOMIMETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 08 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK